Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Balanoposthitis

  • Author: Vladimir O Osipov, MD; Chief Editor: Dirk M Elston, MD  more...
 
Updated: Aug 11, 2016
 

Background

Defined as the inflammation of the foreskin and glans in uncircumcised males, balanoposthitis occurs over a wide age range and may have any of multiple bacterial or fungal origins or be caused by contact dermatitides. Complex infections have been well documented, often from a poorly retractile foreskin and poor hygiene that leads to colonization and overgrowth. Treatment focuses on clearing the acute infection and preventing recurrent inflammation/infection through improved hygiene. Although not as necessary as in the past, circumcision may be considered for refractory or recurrent balanoposthitis. Balanoposthitis should not be confused with balanitis, which is inflammation of the glans penis or the clitoris.

Next

Pathophysiology

Although multiple organisms have been incriminated as causative agents, the patient is empirically treated without obtaining specific organism etiology in most cases. The multicausal origin of balanoposthitis has been emphasized by Fornasa et al, who identified infectious, mechanical/traumatic, or contact dermatitides in 67% of their patients with balanoposthitis.[1] In one third of the patients, a specific cause could not be established even after clinical examination and microbiologic and serologic tests had been performed. Candidal infection appears to be the most common cause of disease.[2] Older men often have other etiologies, including intertrigo, irritant dermatitides, or other fungal infections. Organisms that have been identified include Bacteroides, Gardnerella,[3, 4] and Candida species and beta-hemolytic streptococci. It may also occur as a manifestation of syphilis.[5, 6]

Mayser has proposed that candidal balanitis/balanoposthitis is the most frequent mycotic infection of the penis,[7] although, in general, fungal infections of the penis are rare. In one series, Candida species accounted for 30% of the causative organisms, and beta-hemolytic streptococci accounted for 13%. Wakatsuki detected the following infectious agents as a cause: Candida species in 50%, Streptococcus species in 25%, and no growth in 13% (12% were not tested).[8]

Rare causes include Streptococcus pyogenes,[9, 10] Prevotella melaninogenica, Cordylobia anthropophaga,[11] Providencia stuartii, and Pseudomonas aeruginosa,[12] the last 2 in individuals who are immunocompromised. Reports of an association between human papillomavirus (HPV) infection and long-standing balanoposthitis have been published, but they may reflect a noncausative association.[13, 14, 15] Associations with ulcerative colitis[16] and Crohn disease[17] have also been noted. A case of granulomatous balanoposthitis after intravesical BCG vaccine instillation therapy has been published.[18]

Previous
Next

Epidemiology

Frequency

United States

No studies of incidence have been performed in the United States.

International

In a Japanese study, balanoposthitis was found in 9 (1.5%) of 603 uncircumcised Japanese boys aged 0-15 years.[19] In a study by Hsieh et al, only 1 in 2149 elementary schoolchildren in Hong Kong had balanoposthitis.[20] Dockerty and Sonnex diagnosed Candida species as the cause of balanoposthitis in 35% of 450 men examined in Great Britain.[21] Italian studies have found balanoposthitis in 51 (16%) of 321 patients with genital dermatoses. A long-term Japanese study revealed an incidence of 3-7% per annum.[22]

Race

Breakdowns of race or ethnic background have not been performed, although balanoposthitis, because of its heterogenous etiology, has been described in many races and ethnic backgrounds.

Sex

Balanoposthitis only occurs in males.

Age

Although identified over a wide age range, most studies have centered on the juvenile population (0-5 y) or in sexually active adult males.

Previous
Next

Prognosis

The outcome is often favorable, with treatment failures often leading to further clinical examination and tailoring of the treatment to the particular offending agent. Aside from the associated irritant symptoms, morbidity is limited.

Failure of response in the setting of appropriate treatment should raise the suspicion of malignancy. This necessitates a biopsy to rule out both primary malignancies and secondary malignancies involving the penis. The most common malignancy that mimics balanoposthitis is erythroplasia of Queyrat, although Bowen disease may have some clinical overlap. A single case report has described the presentation of acute promyelocytic leukemia as an ulcerating balanoposthitis.[23]  

Mondor phlebitis of the penis following recurrent candidal balanoposthitis has been reported.[24]

In a patient who is immunocompromised, the presence of a systemic fungal infection can lead to involvement of the penis and often arises as a more deeply involved ulcerating lesion. Treatment of this disease, which can be caused by any number of fungal agents, involves clearing the systemic infection and immunodepression. Mortality is only present in patients who are immunocompromised and often develop balanoposthitis secondary to fungal septicemia.

Previous
Next

Patient Education

For patient education resources, see the Men's Health Center. Also, see the patient education articles Foreskin Problems and Circumcision.

Previous
 
 
Contributor Information and Disclosures
Author

Vladimir O Osipov, MD Pathologist In Charge, QML Townsville

Vladimir O Osipov, MD is a member of the following medical societies: American Society for Clinical Pathology, United States and Canadian Academy of Pathology, Royal College of Pathologists of Australasia, College of American Pathologists

Disclosure: Nothing to disclose.

Coauthor(s)

Milton W Datta, MD Assistant Professor, Departments of Pathology, Urology, and Hematology-Oncology, Emory University School of Medicine

Milton W Datta, MD is a member of the following medical societies: College of American Pathologists, United States and Canadian Academy of Pathology

Disclosure: Nothing to disclose.

Peter Langenstroer, MD Associate Professor, Department of Urology, Medical College of Wisconsin

Peter Langenstroer, MD is a member of the following medical societies: American Urological Association

Disclosure: Nothing to disclose.

Scott M Acker, MD Associate Professor, Director of Dermatopathology, Departments of Dermatology and Pathology, University of Alabama at Birmingham

Scott M Acker, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Society for Clinical Pathology, Southern Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Michael J Wells, MD, FAAD Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Michael J Wells, MD, FAAD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Texas Medical Association

Disclosure: Nothing to disclose.

Jeffrey Meffert, MD Associate Clinical Professor of Dermatology, University of Texas School of Medicine at San Antonio

Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Abdul-Ghani Kibbi, MD Professor and Chair, Department of Dermatology, American University of Beirut Medical Center, Lebanon

Disclosure: Nothing to disclose.

References
  1. Fornasa CV, Calabro A, Miglietta A, Tarantello M, Biasinutto C, Peserico A. Mild balanoposthitis. Genitourin Med. 1994 Oct. 70(5):345-6. [Medline].

  2. Chen J, Zhou YX, Jin XD, Chen SW. Expression of interleukin-2 in Candidal balanoposthitis and its clinical significance. Chin Med J (Engl). 2011 Sep. 124(17):2776-8. [Medline].

  3. Burdge DR, Bowie WR, Chow AW. Gardnerella vaginalis-associated balanoposthitis. Sex Transm Dis. 1986 Jul-Sep. 13(3):159-62. [Medline].

  4. Kinghorn GR, Jones BM, Chowdhury FH, Geary I. Balanoposthitis associated with Gardnerella vaginalis infection in men. Br J Vener Dis. 1982 Apr. 58(2):127-9. [Medline].

  5. Rovira-López R, García-Martínez P, Martín-Ezquerra G, Pujol RM, Aventín DL. Balanoposthitis and Penile Edema: Atypical Manifestations of Primary Syphilis. Sex Transm Dis. 2015 Sep. 42 (9):524-5. [Medline].

  6. Rovira-López R, García-Martínez P, Martín-Ezquerra G, Pujol RM, Aventín DL. Balanoposthitis and Penile Edema: Atypical Manifestations of Primary Syphilis. Sex Transm Dis. 2015 Sep. 42 (9):524-5. [Medline].

  7. Mayser P. Mycotic infections of the penis. Andrologia. 1999. 31 Suppl 1:13-6. [Medline].

  8. Wakatsuki A. [Clinical experience of streptococcal balanoposthitis in 47 healthy adult males]. Hinyokika Kiyo. 2005 Nov. 51(11):737-40. [Medline].

  9. Fuzi M, Csizik E, Gubacs G. [Balanoposthitis caused by Streptococcus pyogenes following sexual intercourse]. Orv Hetil. 1984 Jan 22. 125(4):217-9. [Medline].

  10. Minami M, Wakimoto Y, Matsumoto M, Matsui H, Kubota Y, Okada A, et al. Characterization of Streptococcus pyogenes isolated from balanoposthitis patients presumably transmitted by penile-oral sexual intercourse. Curr Microbiol. 2010 Aug. 61(2):101-5. [Medline].

  11. Petersen CS, Zachariae C. Acute balanoposthitis caused by infestation with Cordylobia anthropophaga. Acta Derm Venereol. 1999 Mar. 79(2):170. [Medline].

  12. Lincopan N, Neves P, Mamizuka EM, Levy CE. Balanoposthitis caused by Pseudomonas aeruginosa co-producing metallo-beta-lactamase and 16S rRNA methylase in children with hematological malignancies. Int J Infect Dis. 2010 Apr. 14(4):e344-7. [Medline].

  13. Birley HD, Luzzi GA, Walker MM, Ryait B, Taylor-Robinson D, Renton AM. The association of human papillomavirus infection with balanoposthitis: a description of five cases with proposals for treatment. Int J STD AIDS. 1994 Mar-Apr. 5(2):139-41. [Medline].

  14. Petersen CS, Larsen J, Albrectsen JM. [Human papillomavirus--(HPV)/balanoposthitis--a new disease?]. Ugeskr Laeger. 1991 Apr 1. 153(14):1000-1. [Medline].

  15. Wikstrom A, von Krogh G, Hedblad MA, Syrjanen S. Papillomavirus-associated balanoposthitis. Genitourin Med. 1994 Jun. 70(3):175-81. [Medline].

  16. Lyttle PH. Ulcerative colitis and balanoposthitis. Int J STD AIDS. 1994 Jan-Feb. 5(1):72-3. [Medline].

  17. Wijesurendra CS, Singh G, Manuel AR, Morris JA. Balanoposthitis--an unusual feature of Crohn's disease?. Int J STD AIDS. 1993 May-Jun. 4(3):184. [Medline].

  18. Yusuke H, Yoshinori H, Kenichi M, Akio H. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy. Int J Urol. 2006 Oct. 13(10):1361-3. [Medline].

  19. Kayaba H, Tamura H, Kitajima S, Fujiwara Y, Kato T, Kato T. Analysis of shape and retractability of the prepuce in 603 Japanese boys. J Urol. 1996 Nov. 156(5):1813-5. [Medline].

  20. Hsieh TF, Chang CH, Chang SS. Foreskin development before adolescence in 2149 schoolboys. Int J Urol. 2006 Jul. 13(7):968-70. [Medline].

  21. Dockerty WG, Sonnex C. Candidal balano-posthitis: a study of diagnostic methods. Genitourin Med. 1995 Dec. 71(6):407-9. [Medline].

  22. Kato S, Ohnishi S, Saka T, Nakajima H, Tanda H. [Clinical statistics on outpatients during the 5 years period (from 1978 Nov. 1st to 1983 Dec. 31st) after the opening of the Urological Clinic of East Sapporo Sanjukai Hospital (II)]. Hinyokika Kiyo. 1984 Nov. 30(11):1677-84. [Medline].

  23. Steinbach F, Essbach U, Florschütz A, Gruss A, Allhoff EP. Ulcerative balanoposthitis as the initial manifestation of acute promyelocytic leukemia. J Urol. 1998 Oct. 160(4):1430-1. [Medline].

  24. Agrawal SK, Singal A, Pandhi D. Mondor's phlebitis of penis following recurrent candidal balanoposthitis. Int J Dermatol. 2005 Jan. 44(1):83-4. [Medline].

  25. Duerden BI. Black-pigmented gram-negative anaerobes in genito-urinary tract and pelvic infections. FEMS Immunol Med Microbiol. 1993 Mar. 6(2-3):223-7. [Medline].

  26. Alsterholm M, Flytstrom I, Leifsdottir R, Faergemann J, Bergbrant IM. Frequency of bacteria, Candida and malassezia species in balanoposthitis. Acta Derm Venereol. 2008. 88(4):331-6. [Medline].

  27. Mallon E, Hawkins D, Dinneen M, et al. Circumcision and genital dermatoses. Arch Dermatol. 2000 Mar. 136(3):350-4. [Medline].

  28. Sonnex C, Croucher PE, Dockerty WG. Balanoposthitis associated with the presence of subpreputial "smegma stones". Genitourin Med. 1997 Dec. 73(6):567. [Medline].

  29. Linden-Castro E, Pelayo-Nieto M, Alias-Melgar A. Penile tuberculosis after intravesical bacille Calmette-Gue´rin immunotherapy. Urology. 2014 Aug. 84(2):e3. [Medline].

  30. Wollina U. Ablative erbium:YAG laser treatment of idiopathic chronic inflammatory non-cicatricial balanoposthitis (Zoon's disease)--a series of 20 patients with long-term outcome. J Cosmet Laser Ther. 2010 Jun. 12(3):120-3. [Medline].

  31. Arumainayagam JT, Sumathipala AH, Smallman LA, Shahmanesh M. Flat condylomata of the penis presenting as patchy balanoposthitis. Genitourin Med. 1990 Aug. 66(4):251-3. [Medline].

  32. Hejase MJ, Bihrle R, Castillo G, Coogan CL. Amebiasis of the penis. Urology. 1996 Jul. 48(1):151-4. [Medline].

  33. Val-Bernal JF, Azcarretazábal T, Garijo MF. Pilonidal sinus of the penis. A report of two cases, one of them associated with actinomycosis. J Cutan Pathol. 1999 Mar. 26(3):155-8. [Medline].

  34. Cree GE, Willis AT, Phillips KD, Brazier JS. Anaerobic balanoposthitis. Br Med J (Clin Res Ed). 1982 Mar 20. 284(6319):859-60. [Medline].

  35. Waugh MA, Evans EG, Nayyar KC, Fong R. Clotrimazole (Canesten) in the treatment of candidal balanitis in men. With incidental observations on diabetic candidal balanoposthitis. Br J Vener Dis. 1978 Jun. 54(3):184-6. [Medline].

  36. Pandya I, Shinojia M, Vadukul D, Marfatia YS. Approach to balanitis/balanoposthitis: Current guidelines. Indian J Sex Transm Dis. 2014 Jul-Dec. 35 (2):155-7. [Medline].

  37. Gonzalvo V, Polo A, Serrallach F, Gutiérrez A, Peyri E. Clinical study of the effectiveness of the "water of the 3 sulfates" on balanitis and balanoposthitis. Actas Urol Esp. 2015 Mar. 39 (2):118-21. [Medline].

  38. [Guideline] Edwards S, Bunker C, Ziller F, van der Meijden WI. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014 May 14. 25(9):615-626. [Medline].

 
Previous
Next
 
Dermis with lymphoplasmacytic infiltrates and dilated blood vessels.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.